drugset
drugset / Trial / NCT06617312

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

NCT06617312 ↗

Phase 2 Recruiting 64 enrolled University of California, Los Angeles
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will randomize 64 non-treatment seeking individuals who smoke cigarettes daily in a double-blind, placebo-controlled laboratory study testing the effects of cytisinicline on the neural substrates of cigarette cue reactivity.

Timeline

Start
2024-12-05
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytisinicline Small molecule 3 mg Oral

Indications

nicotine dependence